Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Gareth Hynes (Oxford, United Kingdom), Gareth Hynes, Christopher Brightling, Mona Bafadhel. Fractional exhaled nitric oxide in chronic obstructive pulmonary disease. Eur Respir J 2015; 46: Suppl. 59, 3993

Member's Comments

No comment yet.

Related content which might interest you: Fractional exhaled nitric oxide in patients with chronic obstructive pulmonary disease Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification Year: 2019 Evaluation of exhaled nitric oxide in idiopathic interstitial lung diseases Source: International Congress 2015 – IIPs: orphan Year: 2015 Exhaled nitric oxide levels in patients with pulmonary hypertension Source: International Congress 2016 – Pulmonary hypertension: the clinic II Year: 2016 Role of fractional exhaled nitric oxide(FeNO) in obstructive airway diseases in Indian population Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Fractional exhaled nitric oxide levels in patients with non-cystic fibrosis bronchiectasis Source: International Congress 2016 – Asthma, bronchiectasis, and the risk factors for respiratory morbidity Year: 2016 Fractional exhaled nitric oxide for eosinophilic inflammation in stable COPD Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers Year: 2017 Severity of scleroderma lung disease is related to alveolar concentration of nitric oxide Source: Eur Respir J 2007; 30: 26-30 Year: 2007 Fractional exhaled nitric oxide in pulmonary hypertension Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside Year: 2016 Exhaled nitric oxide in patients with idiopathic pulmonary fibrosis and pulmonary hypertension Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology? Year: 2008 Measurement of exhaled nitric oxide in patients with pulmonary tuberculosis Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013 Exhaled nitric oxide and hydrogen peroxide in patients with asthma and chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 617s Year: 2007 Exhaled nitric oxide in idiopathic and non-idiopathic interstitial lung disease Source: International Congress 2017 – ILDs: clinical problems Year: 2017 The cycle of the nitric oxide metabolism in patients with COPD and chronic cerebrovascular diseases (CCVD) Source: Annual Congress 2013 –The vulnerable patient and ageing cells Year: 2013 Fractional exhaled nitric oxide is associated with more severe asthma Source: International Congress 2018 – Biomarkers for evaluating asthma Year: 2018 Bronchial and alveolar exhaled nitric oxide as a marker of systemic involvement in patients with Crohn‘s disease Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Exhaled nitric oxide in respiratory diseases other than asthma Source: Eur Respir Monogr 2010; 49: 45-55 Year: 2010 Use of different exhaled nitric oxide multiple flow rate models in COPD Source: Eur Respir J 2007; 29: 651-659 Year: 2007 Exhaled nitric oxide (NO) in patients with chronic cough Source: Eur Respir J 2004; 24: Suppl. 48, 580s Year: 2004 Exhaled nitric oxide increases in chronic eosinophilic pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 509s Year: 2002 An increase in exhaled nitric oxide is not associated with activity in pulmonary sarcoidosis Source: Eur Respir J 2004; 24 : 609-614 Year: 2004